查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1941355

3D生物列印市场报告：按组件、应用、最终用户和地区划分（2026-2034年）

3D Bioprinting Market Report by Component (3D Bioprinters, Scaffolds, Biomaterials), Application (Research, Clinical), End User (Hospitals, Research Organization and Academic Institutes, Biopharmaceuticals Companies), and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3个工作天内

价格

2025年全球3D生物列印市场规模达15.753亿美元。展望未来，IMARC集团预测，到2034年，该市场规模将达到50.4亿美元，2026年至2034年的复合年增长率（CAGR）为13.38%。人口老化加剧、研发投入增加以及市场波动较小被认为是推动市场成长的关键因素。

3D生物列印市场趋势：

加强药物检测与研发

3D生物列印技术对药物测试和临床试验至关重要。它有望显着减少动物实验的需求，这不仅符合伦理，而且成本效益高。 3D生物列印技术的出现使药物研发人员能够在类人3D列印组织上测试新药，更容易识别与人体临床试验相关的併发症，并减少后期失败造成的损失。此外，企业研发投入的增加也进一步推动了3D生物列印等创新技术的需求。例如，美国国会预算办公室 (CBO) 发布的数据显示，截至 2021 年，全球整体製药业在研发方面的支出约为 2,000 亿美元，较 2019 年的 8,300 万美元大幅成长。同样，丹纳赫公司 (Danaher Corporation) 2021 年的研发投资额为 17.42 亿美元，高于 2020 年的 13.48 亿美元。此外，Bio-Rad Laboratories, Inc. 2021 年的投资金额为 8.796 亿美元，高于 2020 年的 8.003 亿美元。预计未来几年，这些对药物测试和药物开发的巨额投资将推动 3D 生物列印市场规模的成长。

技术进步

3D生物列印技术的持续进步为整个市场带来了更多盈利的成长机会。此外，主要市场参与者正在进行合作，共同开发更先进、更有效率的3D生物列印技术。例如，2024年6月，领先的组织模拟技术公司Ronaluk与B9Creations合作，利用Ronaluk的BioBlock技术开发并大规模生产3D生物列印水凝胶。传统方法是将细胞置于人工环境中，而Ronaluk的BioBlock技术则模拟细胞自然形成组织的微环境。这使得列印出来的组织与人体和动物的天然组织结构和功能高度相似。同样，2022年9月，印度科学研究所（IISc）宣布与瑞典生物列印解决方案公司CELLINK合作。此次合作将在其卓越中心（CoE）提供两到三台生物印表机，每台印表机采用不同的列印技术，费用由两家公司各自承担。此外，CELLINK 和印度科学理工学院 (IISc) 将于 2022 年 12 月在班加罗尔联合建立印度首个 3D 生物列印卓越中心。预计此类创新、合作和 3D 生物列印领域的扩张将在预测期内对 3D 生物列印市场的前景产生积极影响。

拓展产品在癌症研究的应用

3D生物列印技术被广泛用于建立逼真的肿瘤模型，这些模型能够忠实地复製真实人体肿瘤的复杂性和微环境。这些生物列印模型使研究人员能够在可控的环境下研究癌症的进展、转移以及肿瘤与基质的相互作用。此外，全球癌症病例的不断增加也为整个市场创造了更大的成长机会。例如，国际癌症研究机构（IARC）估计，2020年全球确诊癌症病例约1,929万例，预计2030年将增加至2,458万例。此外，根据GLOBOCAN的数据，2020年美国约有2281658例新增癌症病例，导致612,390人死于癌症。肺癌和乳癌是人类最常见的两种癌症。根据加拿大癌症协会（CCS）的数据，2020年约有29,800名加拿大人被诊断出罹患肺癌，占新增癌症病例的13%。此外，预计约有21,200名加拿大人将死于肺癌，占2020年所有癌症死亡人数的25%。癌症病例的显着增加推动了对3D生物列印技术的需求，以帮助寻找有效的治疗方法、揭示抗药性机制并实现癌症治疗的个人化。

目录

第一章：序言

第二章：调查范围与调查方法

  • 调查目标
  • 相关利益者
  • 数据来源
    • 主要讯息
    • 二手资讯
  • 市场估值
    • 自下而上的方法
    • 自上而下的方法
  • 调查方法

第三章执行摘要

第四章 引言

第五章：全球3D生物列印市场

  • 市场概览
  • 市场表现
  • 新冠疫情的影响
  • 市场预测

第六章 按组件分類的市场细分

  • 3D生物列印机
    • 主要部分
      • 注射器/挤出式生物列印
      • 喷墨生物列印
      • 磁浮生物列印
      • 雷射辅助生物列印
      • 其他的
  • 鹰架
  • 生物材料
    • 主要部分
      • 活细胞
      • 水凝胶
      • 细胞外基质
      • 其他的

第七章 按应用分類的市场区隔

  • 研究
    • 主要部分
      • 药物研究
      • 再生医学
      • 3D细胞培养
  • 临床
    • 主要部分
      • 皮肤
      • 骨骼和软骨
      • 血管
      • 其他的

第八章 按最终用户分類的市场细分

  • 医院
  • 研究和学术机构
  • 生物製药公司

第九章 按地区分類的市场细分

  • 北美洲
    • 我们
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第十章 SWOT 分析

第十一章 价值链分析

第十二章 波特五力分析

第十三章：定价分析

第十四章 竞争格局

  • 市场结构
  • 主要企业
  • 主要企业简介
    • 3D Systems Inc.
    • Aspect Biosystems Ltd.
    • Cellink
    • Cyfuse Biomedical KK
    • EnvisionTEC GmbH（Desktop Metal Inc.）
    • GeSiM-Gesellschaft fur Silizium-Mikrosysteme mbH
    • Materialise
    • Organovo Holdings Inc.
    • Poietis
    • RegenHU
    • Stratasys Ltd.
Product Code: SR112026A4556

The global 3D bioprinting market size reached USD 1,575.3 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 5,040.0 Million by 2034, exhibiting a growth rate (CAGR) of 13.38% during 2026-2034. The growing geriatric population, increasing focus on research and development (R&D) activities, and less disrupted market represent some of the key factors driving the market growth.

3D Bioprinting Market Analysis:

  • Major Market Drivers: The increasing utilization of 3D bioprinting in personalized medicine is primarily driving the growth of the market. 3D bioprinting can create patient-specific tissues and organs, enabling personalized treatment plans and reducing the risk of transplant rejection.
  • Key Market Trends: The escalating utilization of bioprinting to manufacture complex biomedical devices and implants with precise geometries and biological functionalities is one of the significant trends driving the growth of the market. Furthermore, rapid advancements in 3D bioprinting technology, including improved biomaterials and printing techniques, are also contributing to the market expansion.
  • Competitive Landscape: Some of the leading players operating in the global market include 3D Systems Inc., Aspect Biosystems Ltd., Cellink, Cyfuse Biomedical K.K., EnvisionTEC GmbH (Desktop Metal Inc.), GeSiM - Gesellschaft fur Silizium-Mikrosysteme mbH, Materialise, Organovo Holdings Inc., Poietis, RegenHU, and Stratasys Ltd., among others.
  • Geographical Landscape: According to the report, North America (the United States and Canada) was the largest market for 3D bioprinting. Some of the factors driving the North American 3D bioprinting market include the growing prevalence of various chronic diseases, the wide presence of key players, and increasing private and government investment.
  • Challenges and Opportunities: The global 3D bioprinting market faces challenges such as high costs, technical complexities, and regulatory hurdles. However, it presents opportunities to advance personalized medicine, improve drug testing accuracy, and address organ transplant shortages through innovative tissue engineering solutions.

3D Bioprinting Market Trends:

Increasing Drug Testing and Development

3D bioprinters are highly important for drug testing and clinical trial applications. They are expected to drastically reduce the need for animal trials, thus being ethically beneficial and cost-effective. With the advent of 3D bioprinting, drug developers can easily identify complications associated with human clinical trials by testing new drugs on human-like 3D-printed tissues, thereby reducing losses from late-stage failures. Additionally, the increasing investment in research and development by the companies is further escalating the demand for innovative technologies like 3D bioprinting. For instance, according to the data published by the Congressional Budget Office, in 2021, it has been observed that pharmaceutical industries spent nearly US$ 200 Billion on research and development in 2020 globally compared to US$ 83 Million in 2019. Similarly, Danaher Corporation invested US$ 1,742 Million in its research and development in 2021, as compared to US$ 1,348 Million in 2020. In addition, Bio-Rad Laboratories Inc. invested US$ 879.6 Million in 2021 as compared to US$ 800.3 Million in 2020. Such significant investments in drug trials and drug development are anticipated to propel the 3D bioprinting market size in the coming years.

Technological Advancements

Ongoing technological advancements in 3D bioprinting are further offering lucrative growth opportunities to the overall market. Additionally, various leading market players are collaborating and forming partnerships to develop more advanced and efficient 3D bioprinting technologies. For instance, in June 2024, advanced tissue mimetic technologies company Ronawk partnered with B9Creations to develop and mass-produce 3D bioprinted hydrogels leveraging Ronawk's Bio-Blocks. Unlike traditional methods that force cells into artificial environments, Ronawk's Bio-Blocks recreate conditions that allow cells to form tissues naturally. This results in tissue that closely resembles the native architecture and function of human and animal tissues. Similarly, in September 2022, the Indian Institute of Science (IISc) announced its collaboration with CELLINK, a Sweden-based bioprinting solutions company, to provide two to three bioprinters to the Centre of Excellence (CoE), each of which uses a different printing technology at its own cost. Additionally, in December 2022, CELLINK and IISc jointly established Bengaluru's pioneering 3D Bioprinting Centre of Excellence in India. Such innovations, collaborations, and expansion in 3D bioprinting are projected to positively impact the 3D bioprinting market outlook over the forecasted period.

Growing Product Application in Cancer Research

3D bioprinting is widely used in the creation of realistic tumor models that closely mimic the complexity and microenvironment of actual human tumors. These bioprinted models enable researchers to study cancer progression, metastasis, and tumor-stroma interactions in a controlled setting. Moreover, the escalating cases of cancer across the globe are further offering lucrative growth opportunities to the overall market. For instance, the International Agency for Research on Cancer (IARC) estimated that, in the year 2020, there were about 19.29 million cancer cases. These cases are projected to increase to 24.58 million cases by 2030. Additionally, according to GLOBOCAN, in 2020, there were approximately 2,281,658 new cancer cases diagnosed and 612,390 deaths due to cancer alone in the United States. In addition to this, lung cancer and breast cancer are two of the most common cancers found among individuals. The Canadian Cancer Society (CCS) stated that in 2020, nearly 29,800 Canadians were diagnosed with lung cancer, which accounted for 13% of all new cancer cases. About 21,200 Canadians were expected to die from lung cancer, which represented 25% of all cancer deaths in 2020. Such a substantial growth in cancer cases is augmenting the demand for 3D bioprinting technologies that help identify effective treatments, understand drug resistance mechanisms, and personalize cancer therapies.

Global 3D Bioprinting Industry Segmentation:

Component Insights:

  • 3D Bioprinters
    • Syringe/Extrusion Bioprinting
    • Inkjet Bioprinting
    • Magnetic Levitation Bioprinting
    • Laser-assisted Bioprinting
    • Others
  • Scaffolds
  • Biomaterials
    • Living Cells
    • Hydrogels
    • Extracellular Matrices
    • Others
  • 3D bioprinters (syringe/extrusion bioprinting, inkjet bioprinting, magnetic levitation bioprinting, laser-assisted bioprinting, and others) represented the largest segment
  • The 3D bioprinting market research report has provided a detailed breakup and analysis of the 3D bioprinting market based on the component. This includes 3D bioprinters (syringe/extrusion bioprinting, inkjet bioprinting, magnetic levitation bioprinting, laser-assisted bioprinting, and others), scaffolds, and biomaterials (living cells, hydrogels, extracellular matrices, and others). According to the report, 3D bioprinters (syringe or extrusion bioprinting, inkjet bioprinting, magnetic levitation bioprinting, laser-assisted bioprinting, and others) represented the largest segment.
  • The bolstering demand for 3D bioprinters can be attributed to the increasing utilization of syringe or extrusion-based bioprinting technology in printing various biological compounds or devices. They are widely used in fabricating tissue scaffolds for regenerative medicine, developing organ models for transplant research, and creating realistic tissue models for drug testing and cancer research. Moreover, 3D bioprinters have the ability to produce complex, customized biological structures, improve the accuracy of drug testing, and reduce the need for animal testing. As a result, they are widely used in the fields of tissue engineering, personalized medicine, pharmaceutical development, and medical research.

Application Insights:

  • Research
    • Drug Research
    • Regenerative Medicine
    • 3D Cell Culture
  • Clinical
    • Skin
    • Bone and Cartilage
    • Blood Vessels
    • Others
  • Research (drug research, regenerative medicine, and 3D cell culture) accounted for the largest market share
  • The growth of this segment can be attributed to the widespread utilization of 3D printing technology among researchers to study the effects of different diseases and their progression and possible treatments. Moreover, it reduces the need to use lab animals for medical tests and dangerous trials on humans. Additionally, the 3D bioprinting market forecast by IMARC indicates that the increasing drug development and drug trial activities are bolstering the application of 3D bioprinting in research. For instance, with the COVID-19 pandemic behind, the US Food and Drug Administration (FDA) approved 55 new drugs in 2023, a figure consistent with the number authorized in the last five years (53 per year on average). Thus, 2023 marks the second-best yearly FDA harvest after 2018 (59 approvals) in all the series. Such a significant growth in drug trials and approval is creating a positive outlook for the overall market.

End User Insights:

  • Hospitals
  • Research Organization and Academic Institutes
  • Biopharmaceuticals Companies
  • Biopharmaceuticals companies accounted for the largest market share
  • The 3D bioprinting market statistics by IMARC indicate that the increasing number of target therapies is primarily driving the growth of this segment. In addition to this, the rising collaborations and mergers and acquisition activities among biopharmaceutical companies to develop 3D bioprinting are positively influencing the market. For instance, in June 2022, REGEMAT 3D, a company at the forefront of personalized bio fabrication solutions, announced a partnership with Humabiologics, a company providing human-derived biomaterials for regenerative medicine, in response to the growing demand and to serve a broader life sciences customer base of the industry partners and academic institutions in the European bioprinting and drug testing market.

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
  • North America (the United States and Canada) was the largest market for 3D bioprinting
  • The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for 3D bioprinting.
  • Some of the factors driving the North American 3D bioprinting market included the growing prevalence of various chronic diseases, the presence of key players, and increasing private and government investments. Additionally, new product launches by the key market players in the region, along with the easy allocation of funds to conduct R&D activities, are further creating a positive outlook for the overall market. For instance, in 2022, scientists from Florida Atlantic University and the University of Virginia created a robotic model of the human spine to assist surgeons in anticipating the outcomes of interventions before surgery. Thus, the increasing demand for 3D bioprinting for healthcare physicians is expected to boost the market over the forecast period. Additionally, the rising investments by the regional government authorities in the healthcare sector are projected to propel the 3D bioprinting market share in the coming years.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global 3D bioprinting market. Some of the companies covered in the report include:

  • 3D Systems Inc.
  • Aspect Biosystems Ltd.
  • Cellink
  • Cyfuse Biomedical K.K.
  • EnvisionTEC GmbH (Desktop Metal Inc.)
  • GeSiM - Gesellschaft fur Silizium-Mikrosysteme mbH
  • Materialise
  • Organovo Holdings Inc.
  • Poietis
  • RegenHU
  • Stratasys Ltd.

Key Questions Answered in This Report

  • 1.What was the size of the global 3D bioprinting market in 2025?
  • 2.What is the expected growth rate of the global 3D bioprinting market during 2026-2034?
  • 3.What are the key factors driving the global 3D bioprinting market?
  • 4.What has been the impact of COVID-19 on the global 3D bioprinting market?
  • 5.What is the breakup of the global 3D bioprinting market based on the component?
  • 6.What is the breakup of the global 3D bioprinting market based on the application?
  • 7.What is the breakup of the global 3D bioprinting market based on the end user?
  • 8.What are the key regions in the global 3D bioprinting market?
  • 9.Who are the key players/companies in the global 3D bioprinting market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global 3D Bioprinting Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Component

  • 6.1 3D Bioprinters
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Syringe/Extrusion Bioprinting
      • 6.1.2.2 Inkjet Bioprinting
      • 6.1.2.3 Magnetic Levitation Bioprinting
      • 6.1.2.4 Laser-assisted Bioprinting
      • 6.1.2.5 Others
    • 6.1.3 Market Forecast
  • 6.2 Scaffolds
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Biomaterials
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Living Cells
      • 6.3.2.2 Hydrogels
      • 6.3.2.3 Extracellular Matrices
      • 6.3.2.4 Others
    • 6.3.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Research
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Drug Research
      • 7.1.2.2 Regenerative Medicine
      • 7.1.2.3 3D Cell Culture
    • 7.1.3 Market Forecast
  • 7.2 Clinical
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Skin
      • 7.2.2.2 Bone and Cartilage
      • 7.2.2.3 Blood Vessels
      • 7.2.2.4 Others
    • 7.2.3 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Research Organization and Academic Institutes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Biopharmaceuticals Companies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 3D Systems Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Aspect Biosystems Ltd.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Cellink
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Cyfuse Biomedical K.K.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 EnvisionTEC GmbH (Desktop Metal Inc.)
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 GeSiM - Gesellschaft fur Silizium-Mikrosysteme mbH
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Materialise
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Organovo Holdings Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Poietis
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 RegenHU
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Stratasys Ltd.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials

List of Figures

  • Figure 1: Global: 3D Bioprinting Market: Major Drivers and Challenges
  • Figure 2: Global: 3D Bioprinting Market: Sales Value (in Million USD), 2020-2025
  • Figure 3: Global: 3D Bioprinting Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 4: Global: 3D Bioprinting Market: Breakup by Component (in %), 2025
  • Figure 5: Global: 3D Bioprinting Market: Breakup by Application (in %), 2025
  • Figure 6: Global: 3D Bioprinting Market: Breakup by End User (in %), 2025
  • Figure 7: Global: 3D Bioprinting Market: Breakup by Region (in %), 2025
  • Figure 8: Global: 3D Bioprinting (3D Bioprinters) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: 3D Bioprinting (3D Bioprinters) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: 3D Bioprinting (Scaffolds) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: 3D Bioprinting (Scaffolds) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: 3D Bioprinting (Biomaterials) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: 3D Bioprinting (Biomaterials) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: 3D Bioprinting (Research) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: 3D Bioprinting (Research) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: 3D Bioprinting (Clinical) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: 3D Bioprinting (Clinical) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: 3D Bioprinting (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: 3D Bioprinting (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: 3D Bioprinting (Research Organization and Academic Institutes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: 3D Bioprinting (Research Organization and Academic Institutes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: 3D Bioprinting (Biopharmaceuticals Companies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: 3D Bioprinting (Biopharmaceuticals Companies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: North America: 3D Bioprinting Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: North America: 3D Bioprinting Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: United States: 3D Bioprinting Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: United States: 3D Bioprinting Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Canada: 3D Bioprinting Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Canada: 3D Bioprinting Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Asia-Pacific: 3D Bioprinting Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Asia-Pacific: 3D Bioprinting Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: China: 3D Bioprinting Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: China: 3D Bioprinting Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Japan: 3D Bioprinting Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Japan: 3D Bioprinting Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: India: 3D Bioprinting Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: India: 3D Bioprinting Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: South Korea: 3D Bioprinting Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: South Korea: 3D Bioprinting Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Australia: 3D Bioprinting Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Australia: 3D Bioprinting Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Indonesia: 3D Bioprinting Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Indonesia: 3D Bioprinting Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Others: 3D Bioprinting Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Others: 3D Bioprinting Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Europe: 3D Bioprinting Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Europe: 3D Bioprinting Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Germany: 3D Bioprinting Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Germany: 3D Bioprinting Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: France: 3D Bioprinting Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: France: 3D Bioprinting Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: United Kingdom: 3D Bioprinting Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: United Kingdom: 3D Bioprinting Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Italy: 3D Bioprinting Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Italy: 3D Bioprinting Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Spain: 3D Bioprinting Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Spain: 3D Bioprinting Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Russia: 3D Bioprinting Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Russia: 3D Bioprinting Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Others: 3D Bioprinting Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Others: 3D Bioprinting Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Latin America: 3D Bioprinting Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Latin America: 3D Bioprinting Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Brazil: 3D Bioprinting Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Brazil: 3D Bioprinting Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Mexico: 3D Bioprinting Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Mexico: 3D Bioprinting Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Others: 3D Bioprinting Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Others: 3D Bioprinting Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Middle East and Africa: 3D Bioprinting Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Middle East and Africa: 3D Bioprinting Market: Breakup by Country (in %), 2025
  • Figure 72: Middle East and Africa: 3D Bioprinting Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Global: 3D Bioprinting Industry: SWOT Analysis
  • Figure 74: Global: 3D Bioprinting Industry: Value Chain Analysis
  • Figure 75: Global: 3D Bioprinting Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: 3D Bioprinting Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: 3D Bioprinting Market Forecast: Breakup by Component (in Million USD), 2026-2034
  • Table 3: Global: 3D Bioprinting Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: 3D Bioprinting Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: 3D Bioprinting Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: 3D Bioprinting Market: Competitive Structure
  • Table 7: Global: 3D Bioprinting Market: Key Players